Josh F. Peterson
Josh F. Peterson
Professor, Vanderbilt University Medical Center
Email confirmado em vumc.org
Título
Citado por
Citado por
Ano
The incidence and severity of adverse events affecting patients after discharge from the hospital
AJ Forster, HJ Murff, JF Peterson, TK Gandhi, DW Bates
Annals of internal medicine 138 (3), 161-167, 2003
19552003
Adverse drug events in ambulatory care
TK Gandhi, SN Weingart, J Borus, AC Seger, J Peterson, E Burdick, ...
New England Journal of Medicine 348 (16), 1556-1564, 2003
16422003
Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients
P Pandharipande, A Shintani, J Peterson, BT Pun, GR Wilkinson, ...
The Journal of the American Society of Anesthesiologists 104 (1), 21-26, 2006
11872006
Delirium and its motoric subtypes: a study of 614 critically ill patients
JF Peterson, BT Pun, RS Dittus, JWW Thomason, JC Jackson, ...
Journal of the American Geriatrics Society 54 (3), 479-484, 2006
7452006
Intensive care unit delirium is an independent predictor of longer hospital stay: a prospective analysis of 261 non-ventilated patients
JWW Thomason, A Shintani, JF Peterson, BT Pun, JC Jackson, EW Ely
Critical care 9 (4), 1-7, 2005
6372005
Adverse drug events occurring following hospital discharge
AJ Forster, HJ Murff, JF Peterson, TK Gandhi, DW Bates
Journal of general internal medicine 20 (4), 317-323, 2005
5432005
Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project
JM Pulley, JC Denny, JF Peterson, GR Bernard, CL Vnencak‐Jones, ...
Clinical Pharmacology & Therapeutics 92 (1), 87-95, 2012
3382012
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing
KA Birdwell, B Decker, JM Barbarino, JF Peterson, CM Stein, W Sadee, ...
Clinical Pharmacology & Therapeutics 98 (1), 19-24, 2015
3112015
Large-scale implementation of sedation and delirium monitoring in the intensive care unit: a report from two medical centers
BT Pun, SM Gordon, JF Peterson, AK Shintani, JC Jackson, J Foss, ...
Critical care medicine 33 (6), 1199-1205, 2005
3112005
Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)
KE Caudle, HM Dunnenberger, RR Freimuth, JF Peterson, JD Burlison, ...
Genetics in Medicine 19 (2), 215-223, 2017
2722017
Commonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury
ED Siew, ME Matheny, TA Ikizler, JB Lewis, RA Miller, LR Waitman, ...
Kidney international 77 (6), 536-542, 2010
2122010
Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing
SL Van Driest, Y Shi, EA Bowton, JS Schildcrout, JF Peterson, J Pulley, ...
Clinical Pharmacology & Therapeutics 95 (4), 423-431, 2014
2072014
The design and evaluation of prototype eco-feedback displays for fixture-level water usage data
J Froehlich, L Findlater, M Ostergren, S Ramanathan, J Peterson, I Wragg, ...
Proceedings of the SIGCHI conference on human factors in computing systems …, 2012
1872012
Design and anticipated outcomes of the eMERGE‐PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems
LJ Rasmussen‐Torvik, SC Stallings, AS Gordon, B Almoguera, ...
Clinical Pharmacology & Therapeutics 96 (4), 482-489, 2014
1862014
Linking laboratory and pharmacy: opportunities for reducing errors and improving care
GD Schiff, D Klass, J Peterson, G Shah, DW Bates
Archives of internal medicine 163 (8), 893-900, 2003
1792003
Estimating baseline kidney function in hospitalized patients with impaired kidney function
ED Siew, TA Ikizler, ME Matheny, Y Shi, JS Schildcrout, I Danciu, ...
Clinical journal of the American society of nephrology 7 (5), 712-719, 2012
1542012
Outpatient nephrology referral rates after acute kidney injury
ED Siew, JF Peterson, SK Eden, AM Hung, T Speroff, TA Ikizler, ...
Journal of the American Society of Nephrology 23 (2), 305-312, 2012
1512012
Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping
JS Schildcrout, JC Denny, E Bowton, W Gregg, JM Pulley, MA Basford, ...
Clinical Pharmacology & Therapeutics 92 (2), 235-242, 2012
1502012
The pharmacogenomics research network translational pharmacogenetics program: overcoming challenges of real‐world implementation
AR Shuldiner, MV Relling, JF Peterson, K Hicks, RR Freimuth, W Sadee, ...
Clinical Pharmacology & Therapeutics 94 (2), 207-210, 2013
1492013
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
LH Cavallari, CR Lee, AL Beitelshees, RM Cooper-DeHoff, JD Duarte, ...
JACC: Cardiovascular Interventions 11 (2), 181-191, 2018
1482018
O sistema não pode efectuar a operação agora. Tente novamente mais tarde.
Artigos 1–20